دورية أكاديمية

Therapeutic apheresis: is it safe in children with kidney disease?

التفاصيل البيبلوغرافية
العنوان: Therapeutic apheresis: is it safe in children with kidney disease?
المؤلفون: Kalenderoğlu, Muhammed Doğukan, Çomak, Elif, Aksoy, Gülşah Kaya, Bilge, Uğur, Küpesiz, Osman Alphan, Koyun, Mustafa, Akman, Sema
المصدر: Pediatric Nephrology; Aug2024, Vol. 39 Issue 8, p2451-2457, 7p
مصطلحات موضوعية: PATIENT safety, IMMUNOGLOBULINS, RETROSPECTIVE studies, DESCRIPTIVE statistics, HEMOLYTIC-uremic syndrome, ALLERGIES, PEDIATRICS, GRAFT rejection, SURGICAL complications, MEDICAL records, ACQUISITION of data, TECHNOLOGY, BLOOD circulation, HEMAPHERESIS, KIDNEY diseases, IMMUNOADSORPTION, DISEASE incidence, DISEASE complications, CHILDREN
مصطلحات جغرافية: TURKEY
مستخلص: Background: Therapeutic apheresis (TA) is already used to treat various diseases in the field of nephrology. The aim of this study was to evaluate the frequency and types of complications that occur during TA in children with kidney disease. Methods: Records of children (≤ 18 years) who underwent TA between 2007 and 2022 were retrospectively reviewed. Children with missing data and those with a diagnosis of nonnephrological disease were excluded. Results: A total of 1214 TA sessions, including 1147 therapeutic plasma exchange (TPE) sessions and 67 immunoadsorption (IA) sessions, were performed on the 108 patients enrolled in the study. Forty-seven percent of the patients were male, and the mean age was 12.22 ± 4.47 years. Posttransplant antibody-mediated rejection (64.8%) and hemolytic uremic syndrome (14.8%) were the most common diagnoses indicating TA. Overall, 17 different complications occurred in 58 sessions (4.8%), and 53 sessions (4.6%) were not completed because of these complications. The distribution of complications among the patients was as follows: 41.4% had technical complications, 25.9% had allergic complications, and 32.7% had others. The most common technical complication was insufficient flow (37.5%). The incidence of complications was greater in patients aged 3–6 years than in patients in the other age groups (p = 0.031). The primary disease, type of vascular access, and rate of fresh frozen plasma/albumin use were similar between patients with and without complications (p values of 0.359 and 0.125 and 0.118, respectively). Conclusions: Our study showed that complications occurred in only 4.8% of TA sessions. The most common complication was technical problems. [ABSTRACT FROM AUTHOR]
Copyright of Pediatric Nephrology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:0931041X
DOI:10.1007/s00467-024-06346-0